Ethylene

Ethylene

SCHEMBL6994474

C=C.CCOC(C)OCC.COc1ccc2c(c1)S(=O)(=O)NCC2=O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 4/20 0.38
CA12 O43570 3/20 0.36
CA9 Q16790 3/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 1/20 0.36
CA7 P43166 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
SLC40A1 Q9NP59 1/20 0.34
METAP1 P53582 1/20 0.33
ALPI P09923 1/20 0.33
APAF1 O14727 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP19A1 P11511 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
MPO P05164 1/20 0.32
ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6988767 0.91 L3MBTL1 (0.39) GRIA2CA12CA9CA1CA2
SCHEMBL5185504 0.85 GRIA2 (0.47) GRIA2CA12CA9CA1CA2
Ethylene SCHEMBL6995383 0.85 CHEK1 (0.35) GRIA2CA12CA9CA1CA2
Ethylene SCHEMBL6989724 0.82 CA12 (0.36) CA12CA9CA1CA2CA4
Ethylene SCHEMBL6995835 0.78 CHEK1 (0.41) GRIA2CA12CA9CA1CA2
Cyclopropane SCHEMBL6998820 0.77 KDM4E (0.36) CA12CA9CA1CA2CA4
Ethylene SCHEMBL6993460 0.76 KCNA5 (0.38) ALPIALDH1A1KDM4EELANE
Ethylene SCHEMBL7110313 0.72 RET (0.42) CA12CA9CA1CA2CA4
SCHEMBL30184574 0.67 GRIA2 (0.50) GRIA2CA12CA9CA1CA2
Ethylene SCHEMBL6994583 0.67 L3MBTL1 (0.43) L3MBTL1APAF1ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
EP-0749967-B1 Substituted benzothiazine derivative SUNTORY LTD (JP) 2003-01-22 EP disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
US-5874429-A ANTIISCHEMIC AGENTS; CEREBROVASCULAR DISORDERS; CIRCULATORY IDSORDERS SUNTORY LIMITED (JP) 1999-02-23 US disclosed
EP-0749967-A1 Substituted benzothiazine derivative SUNTORY LIMITED (JP) 1996-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 GRIA2 1108/4885CA12 4559/4885CA9 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.